Staying informed about key updates regarding regulatory compliance is essential for businesses using antimicrobial technologies. At BioCote, we are excited to share recent developments regarding the European Biocidal Products Regulation (EU-BPR) and its implications for silver zinc zeolite.
European Biocidal Products Regulation (EU-BPR) and Approval Process
The EU Biocidal Products Regulation (EU-BPR), established under Regulation (EU) No 528/2012, governs the market approval and usage of biocidal products aimed at safeguarding humans and the environment from harmful chemicals and substances. This comprehensive regulation ensures rigorous evaluations and assessments of active substances for safety and efficacy.
Regulatory Progress and Silver Zinc Zeolite Approval
At the recent 50th Biocidal Products Committee (BPC-50) meeting held in February 2024, silver zinc zeolite received positive support for approval as an active substance under multiple product-types (PTs), including disinfectants and algaecides not intended for direct application to humans or animals (PT2), film preservatives (PT7), and fibre, leather, rubber, and polymerised materials preservatives (PT9). This endorsement signifies a crucial step towards regulatory acceptance.
The recent endorsement of silver zinc zeolite as an active substance under various PTs within the EU-BPR highlights a pivotal moment for antimicrobial technologies. This milestone highlights the regulatory acceptance and potential applications of our innovative antimicrobial technology.
Implications for Potential Antimicrobial Applications
For businesses considering the integration of antimicrobial properties into plastic materials, this development is particularly significant. The pending approval of silver zinc zeolite under EU-BPR PT9 offers a streamlined pathway for incorporating our technology into plastic applications, ensuring compliance with stringent regulatory standards, and enhancing product value.
BioCote’s Commitment to Compliance and Innovation
At BioCote, we understand the importance of regulatory alignment and product safety. Our proven antimicrobial solutions are engineered to meet the highest standards of efficacy and regulatory compliance. With impending regulatory approval, customers can leverage BioCote’s technology confidently, knowing that our solutions adhere to stringent EU regulations.
MEBSS : Managing Microorganisms In Veterinary Environments
BioCote® conducted targeted testing against the MEBSS panel, five bacteria relevant to veterinary environments, including MRSA, E. coli, Bordetella, Salmonella, and Streptococcus. Using ISO 22196 methodology, results demonstrated up to 99.98% reduction across all organisms tested, supporting improved surface performance alongside routine cleaning practices.
Elevating Hygiene from the Ground Up with Teco Polimeri
Italian flooring specialist Teco Polimeri has integrated BioCote® antimicrobial technology directly into its Linea Antibatterica epoxy resin systems. Designed for demanding food, pharmaceutical, and healthcare environments, these seamless, durable floors provide continuous surface protection against bacterial growth between routine cleaning cycles.
